OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 24, 2018
Flexibility, innovation, and creativity are critical for success in navigating the challenges facing the bio/pharmaceutical industry.
KBI Biopharma's acquisition of Elion Labs expands KBI's biophysical and analytical characterization capabilities.
January 23, 2018
Paragon Bioservices will build a new cGMP facility in Maryland and expand its existing cGMP facility at the University of Maryland's BioPark.
January 16, 2018
The acquisition strengthens Charles River Laboratories’ capabilities in the oncology and immunology therapeutic areas.
A ceremony was held at Cambrex’s Karlskoga facility to mark the commencement of a long-term manufacturing agreement with AstraZeneca for a key intermediate.
January 04, 2018
The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.
January 02, 2018
Bio/pharma professionals manage expectations amid industry uncertainty.
The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
December 20, 2017
MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.
December 19, 2017
The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.